Cancer Nanotechnology is a cutting-edge peer-reviewed journal dedicated to advancing the field of cancer research through innovative nanotechnology applications. Published by SPRINGER WIEN, this open-access journal, established in 2010, provides a vital platform for the dissemination of high-quality research with a focus on the intersection of nanotechnology, oncology, and biomedical engineering. With a commitment to promoting accessibility and fostering collaboration, Cancer Nanotechnology has gained impressive rankings within specialized categories, including Q2 in Biomedical Engineering and Pharmaceutical Science. The journal's rigorous selection process ensures that only the most impactful studies reach its audience, making it a must-read for researchers, professionals, and students eager to explore the latest advancements and methodologies in cancer treatment. With its scope encompassing critical topics that bridge multiple disciplines—including physical chemistry and toxicology—Cancer Nanotechnology positions itself as an influential resource for shaping the future of cancer therapies.

JOURNAL OF DRUG TARGETING, published by Taylor & Francis Ltd, is a premier academic journal dedicated to advancing the field of pharmaceutical sciences with a strong focus on drug delivery and targeting methodologies. With an impressive impact factor and recognized as a Q1 journal in the Pharmaceutical Science category, it ranks #23 out of 183 in Pharmacology, Toxicology and Pharmaceutics, placing it within the top 13% of journals in its field. The journal provides a platform for interdisciplinary research, showcasing innovative techniques and breakthrough findings that serve to improve therapeutic efficacy through precision targeting. Although it operates under a subscription model, researchers benefit from extensive access to pivotal studies spanning from 1986 to 2024. The JOURNAL OF DRUG TARGETING aims to foster collaboration among academics, professionals, and students, making it an essential resource for those seeking to leverage the latest advancements in drug development and delivery systems for improved healthcare outcomes.

The Journal of Nanostructure in Chemistry, published by Springer Heidelberg, stands at the forefront of nanotechnology and its applications in the field of chemistry. With an impressive Q1 ranking in Chemistry (Miscellaneous) as of 2023, this journal offers a platform for disseminating groundbreaking research and innovative practices that shape the future of nanostructured materials. Recognized among the top-tier publications in its category—with a commendable 96th percentile ranking in Scopus—this journal provides researchers, professionals, and students alike with invaluable insights into the intricate interplay between nanoscale structures and chemical principles. Despite being a non-open access platform, its commitment to high-quality, peer-reviewed content continues to drive scientific discourse and collaboration within the international research community. The Journal of Nanostructure in Chemistry, which spans from 2013 to 2024, is dedicated to advancing knowledge and fostering innovation in nanochemistry, making it an essential resource for anyone looking to stay ahead in this rapidly evolving discipline.

Nano Today is a prestigious journal published by ELSEVIER SCI LTD that stands at the forefront of nanoscience and nanotechnology research. With an impact factor that underscores its significance, this journal has achieved remarkable rankings in several key categories as of 2023, including Q1 positions in Bioengineering, Biomedical Engineering, Biotechnology, Materials Science, and Pharmaceutical Science, making it an essential resource for scholars and professionals alike. ISSN 1748-0132 and E-ISSN 1878-044X, the journal serves as a vital platform for disseminating cutting-edge research findings and innovative applications in the field. Although open access options are not available, the journal's rich repository of peer-reviewed articles provides invaluable insights into the latest advancements in nanotechnologies. Based in the Netherlands, Nano Today not only connects a global network of researchers but also propels forward the conversation on the transformative potential of nanomaterials across multiple disciplines. With a commitment to advancing knowledge and fostering innovation, Nano Today is an indispensable tool for academics and practitioners dedicated to pushing the boundaries of scientific exploration.

The Journal of Nano Research, published by Trans Tech Publications Ltd, is a distinguished academic journal dedicated to the rapidly evolving field of nanotechnology and materials science. With an ISSN of 1662-5250 and an E-ISSN of 1661-9897, the journal has been an important platform for researchers and professionals since its inception in 2008, continuing to provide high-quality peer-reviewed research through to 2024. Nestled in Switzerland, the Journal of Nano Research plays a pivotal role in disseminating cutting-edge findings, as recognized by its categorization in Q3 for Materials Science and Physics while being positioned in Q4 for Nanoscience and Nanotechnology as of 2023. With Scopus rankings highlighting its impact, including Rank #129 in general Physics and Astronomy and Rank #300 in Materials Science, this journal is crucial for academics seeking to stay ahead in research trends and innovations in nano-related disciplines. Although it operates under a subscription model, the journal's objectives include fostering collaboration and knowledge-sharing among researchers, making it an invaluable resource for anyone immersed in the world of nanotechnology.

International Journal of Pharmaceutics-X is a premier open access journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmaceutical sciences. Launched in 2019, this journal has quickly ascended to the Q1 category in the 2023 Category Quartiles, reflecting its high impact and the quality of research it promotes. With a current Scopus ranking of #49 out of 183 in the Pharmacology, Toxicology and Pharmaceutics category, this journal occupies the 73rd percentile, showcasing its significant influence within the scholarly community. Emphasizing innovative research and novel applications, the International Journal of Pharmaceutics-X offers a platform for researchers, professionals, and students to disseminate their findings, making crucial contributions to the global pharmaceutical landscape. The journal is based in the Netherlands, presenting a vibrant hub for scientific discourse and collaboration in a rapidly evolving field.

Nanotechnology Reviews, published by DE GRUYTER POLAND SP Z O O, stands at the forefront of the multidisciplinary field of nanoscience and nanotechnology. With an Open Access model adopted since 2019, this journal, identifiable by its ISSN 2191-9089 and E-ISSN 2191-9097, disseminates vital research that is accessible to a global audience. The journal is located in Germany and has established itself as a premier platform for innovative research, boasting impressive quartile rankings: Q1 across several categories including Biotechnology, Energy Engineering, and Materials Science, as well as a Q2 classification in Biomaterials as of 2023. The diverse scope enables authors to contribute to a range of topics, from biomedical applications to energy solutions and advanced materials, making it essential reading for researchers, professionals, and students passionate about cutting-edge developments. Additionally, with Scopus rankings highlighting its value across various domains and robust percentiles, including 94 in Engineering (miscellaneous), 93 in Medicine (miscellaneous), and 88 in Biotechnology, Nanotechnology Reviews is an influential and respected journal that fosters scientific dialogue and innovation.

JOURNAL OF NANOPARTICLE RESEARCH, published by SPRINGER, is a pivotal platform in the interdisciplinary field of nanotechnology, encompassing atomic and molecular physics, bioengineering, chemistry, condensed matter physics, and materials science. Operating since 1999 and converging through 2024, this journal presents cutting-edge research and innovations in nanoparticle science, aiming to bridge theoretical studies with practical applications. With a diverse scope that attracts articles ranked in various Q2 and Q3 category quartiles across its fields, including Bioengineering and Nanoscience and Nanotechnology, it ranks favorably within Scopus metrics, ensuring high visibility and impact among researchers. While the journal operates under traditional access models, it remains a critical resource for professionals and students alike, empowering them to advance their knowledge and drive future discoveries in this rapidly evolving area of study.

Nanomedicine, published by Future Medicine Ltd, is a premier academic journal dedicated to the rapidly evolving field of nanotechnology in medicine. With an emphasis on innovative research and applications, this journal encompasses a broad spectrum of topics including bioengineering, biomedical engineering, and nanoscience, among others. Featuring an impressive Q1 ranking in Development and multiple Q2 rankings across significant categories, it serves as a pivotal resource for researchers and professionals aiming to stay at the forefront of advancements in these disciplines. While the journal is not open access, it is accessible through various institutional subscriptions, ensuring wide dissemination of cutting-edge findings. Notably, it has achieved substantial impact within the scientific community, indicated by its high rankings in Scopus and overall commitment to enhancing the understanding and application of nanomedicine. This journal is a vital conduit for fostering collaborations and innovations that transcend traditional medical paradigms.

BioNanoScience is an esteemed academic journal published by SPRINGER, dedicated to the interdisciplinary field of bioengineering and biomedical engineering. With an ISSN of 2191-1630 and an E-ISSN of 2191-1649, the journal has established itself as a significant platform for sharing innovative research and developments in nanotechnology as applied to biomedical contexts. Although it operates under a subscription model, the journal maintains a strong impact within its field, achieving a Q3 quartile ranking in both categories for 2023 and has a solid standing in Scopus rankings, where it ranks #129 out of 303 in Biomedical Engineering and #87 out of 162 in Bioengineering. The journal not only aims to publish high-quality research, but also seeks to foster collaboration between scientists, engineers, and healthcare professionals to address pressing global health challenges through nanotechnology. As an essential resource for researchers, professionals, and students, BioNanoScience continues to contribute to the advancement of knowledge and innovation in bioengineering.